ALTMAN STEVEN R 4
4 · DEXCOM INC · Filed Jan 17, 2024
Insider Transaction Report
Form 4
DEXCOM INCDXCM
ALTMAN STEVEN R
Director
Transactions
- Sale
Common Stock
2024-01-16$123.24/sh−1,108$136,548→ 53,132 total(indirect: By Trust) - Sale
Common Stock
2024-01-16$121.97/sh−460$56,104→ 54,240 total(indirect: By Trust)
Holdings
- 2,885
Common Stock
Footnotes (4)
- [F1]On May 30, 2023, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $121.44 to $122.24 per share. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee.
- [F4]This transaction was executed in multiple trades at prices ranging from $122.86 to $123.65 per share. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.